Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 ...

French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in ...

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

The China-based subsidiary of French pharma major Sanofi revealed it has signed a memorandum of cooperation with Beijing ...

JPMorgan raised the firm’s price target on Sanofi (SNY) to EUR 105 from EUR 100 and keeps a Neutral rating on the shares.Don't Miss our Black ...

French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in ...

Sanofi a leading global healthcare company invests ampeuro1 billion in Beijing for a new insulin plant creating jobs and bolstering China health ...

A gigante farmacêutica francesa Sanofi investirá cerca de 1 bilhão de euros (US$ 1,05 bilhão) para estabelecer uma nova base ...

The divestiture of the Czech facility follows U.S.-based Novavax's licensing deal worth at least $1.2 billion with French ...

Sanofi has managed the daunting task faced by managers worldwide: hauling its employees back to the office with minimal fuss. That’s an impressive feat for a company that said last year it was ...